Finland · Delayed Price · Currency is EUR Biohit Oyj Statistics
Total Valuation
Biohit Oyj has a market cap or net worth of EUR 40.75 million. The enterprise value is 39.25 million.
| Market Cap | 40.75M |
| Enterprise Value | 39.25M |
Important Dates
The last earnings date was Wednesday, August 5, 2026.
| Earnings Date | Aug 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Biohit Oyj has 15.21 million shares outstanding. The number of shares has increased by 5.70% in one year.
| Current Share Class | 12.23M |
| Shares Outstanding | 15.21M |
| Shares Change (YoY) | +5.70% |
| Shares Change (QoQ) | +2.62% |
| Owned by Insiders (%) | 40.21% |
| Owned by Institutions (%) | 1.47% |
| Float | 4.50M |
Valuation Ratios
The trailing PE ratio is 13.54 and the forward PE ratio is 15.76.
| PE Ratio | 13.54 |
| Forward PE | 15.76 |
| PS Ratio | 2.53 |
| PB Ratio | 2.52 |
| P/TBV Ratio | 2.66 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 12.51 |
| EV / Sales | 2.43 |
| EV / EBITDA | 10.33 |
| EV / EBIT | 12.27 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.31, with a Debt / Equity ratio of 0.09.
| Current Ratio | 2.31 |
| Quick Ratio | 2.06 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | 0.37 |
| Debt / FCF | -0.68 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 21.42% and return on invested capital (ROIC) is 22.97%.
| Return on Equity (ROE) | 21.42% |
| Return on Assets (ROA) | 11.59% |
| Return on Invested Capital (ROIC) | 22.97% |
| Return on Capital Employed (ROCE) | 18.39% |
| Weighted Average Cost of Capital (WACC) | 7.18% |
| Revenue Per Employee | 350,696 |
| Profits Per Employee | 68,217 |
| Employee Count | 46 |
| Asset Turnover | 0.84 |
| Inventory Turnover | 6.10 |
Taxes
In the past 12 months, Biohit Oyj has paid 163,000 in taxes.
| Income Tax | 163,000 |
| Effective Tax Rate | 4.94% |
Stock Price Statistics
The stock price has decreased by -7.27% in the last 52 weeks. The beta is 0.58, so Biohit Oyj's price volatility has been lower than the market average.
| Beta (5Y) | 0.58 |
| 52-Week Price Change | -7.27% |
| 50-Day Moving Average | 2.67 |
| 200-Day Moving Average | 2.86 |
| Relative Strength Index (RSI) | 47.50 |
| Average Volume (20 Days) | 7,841 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Biohit Oyj had revenue of EUR 16.13 million and earned 3.14 million in profits. Earnings per share was 0.20.
| Revenue | 16.13M |
| Gross Profit | 11.25M |
| Operating Income | 3.55M |
| Pretax Income | 3.30M |
| Net Income | 3.14M |
| EBITDA | 3.80M |
| EBIT | 3.20M |
| Earnings Per Share (EPS) | 0.20 |
Balance Sheet
The company has 2.90 million in cash and 1.40 million in debt, with a net cash position of 1.50 million or 0.10 per share.
| Cash & Cash Equivalents | 2.90M |
| Total Debt | 1.40M |
| Net Cash | 1.50M |
| Net Cash Per Share | 0.10 |
| Equity (Book Value) | 16.20M |
| Book Value Per Share | 1.12 |
| Working Capital | 4.20M |
Cash Flow
In the last 12 months, operating cash flow was -1.15 million and capital expenditures -915,000, giving a free cash flow of -2.06 million.
| Operating Cash Flow | -1.15M |
| Capital Expenditures | -915,000 |
| Depreciation & Amortization | 81,000 |
| Net Borrowing | -302,000 |
| Free Cash Flow | -2.06M |
| FCF Per Share | -0.14 |
Margins
Gross margin is 69.73%, with operating and profit margins of 22.02% and 19.45%.
| Gross Margin | 69.73% |
| Operating Margin | 22.02% |
| Pretax Margin | 20.46% |
| Profit Margin | 19.45% |
| EBITDA Margin | 23.60% |
| EBIT Margin | 19.88% |
| FCF Margin | n/a |
Dividends & Yields
Biohit Oyj does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.70% |
| Shareholder Yield | -5.70% |
| Earnings Yield | 7.70% |
| FCF Yield | -5.06% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |